CORVEL CORP
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenues | $958.5M+7.0% | $895.6M+12.6% | $795.3M+10.7% | $718.6M+11.2% | $646.2M |
| Cost of revenues | $725.7M+5.8% | $685.9M+10.0% | $623.6M+11.3% | $560.3M+13.4% | $494.1M |
| Gross profit | $232.9M+11.0% | $209.7M+22.2% | $171.7M+8.5% | $158.3M+4.0% | $152.1M |
| General and administrative | $89.7M+0.9% | $88.9M+16.1% | $76.6M+3.9% | $73.7M+9.0% | $67.6M |
| Income before income taxes | $143.1M+18.5% | $120.8M+27.0% | $95.1M+12.5% | $84.6M+0.0% | $84.5M |
| Income tax provision | $32.8M+27.8% | $25.7M+36.1% | $18.8M+3.6% | $18.2M+0.5% | $18.1M |
| Net income | $110.3M+16.0% | $95.2M+24.8% | $76.3M+14.9% | $66.4M-0.1% | $66.4M |
| Basic | $51.3M-0.2% | $51.4M+0.0% | $51.4M-1.2% | $52.0M+192.8% | $17.8M |
| Diluted | $51.6M-0.7% | $52.0M-0.1% | $52.0M-1.4% | $52.8M+191.1% | $18.1M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
CorVel reports Q4 FY2026 EPS of $0.61, up 20% YoY, with revenues of $249 million, up 7% YoY
“CERIS is benefiting from the healthcare industry's shift toward proactive payment accuracy and cost management, with strong demand for its integrated prepay and post-pay platform”
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-11 | 2026-06-11 | Combs Michael G | CEO & President | Sale | 7,000 | $60.55 | $424K | 12.8K | View | |
| 2026-06-10 | 2026-06-11 | Combs Michael G | CEO & President | Sale | 7,000 | $61.38 | $430K | 19.8K | View | |
| 2026-06-09 | 2026-06-11 | Combs Michael G | CEO & President | Sale | 7,000 | $60.90 | $426K | 26.8K | View | |
| 2026-06-09 | 2026-06-10 | MICHAEL JEFFREY J | Director | Sale | 9,000 | $60.98 | $549K | 559.7K | View | |
| 2026-05-26 | 2026-05-27 | Yoss Jennifer | Vice President of Accounting | Sale | 1,999 | $61.02 | $122K | 2,173 | View |
Informational purposes only, not investment advice.